Skip to Content

Dronedarone

In the US, Dronedarone (dronedarone systemic) is a member of the drug class group III antiarrhythmics and is used to treat Atrial Fibrillation and Atrial Flutter.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C01BD07

CAS registry number (Chemical Abstracts Service)

0141626-36-0

Chemical Formula

C31-H44-N2-O5-S

Molecular Weight

556

Therapeutic Category

Antiarrhythmic agent

Chemical Names

Metanesulfonamide, N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]-

N,N-dibutyl-3-[4-[(2-butyl-5-metylsulfonamido)benzofuran-3-ylcarbonyl]phenoxy]propylamine

N-[2-butyl-3-[p-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]metanesulfonamide (WHO)

Foreign Names

  • Dronedaronum (Latin)
  • Dronedaron (German)
  • DronĂ©darone (French)
  • Dronedarona (Spanish)

Generic Names

  • Dronedarone (OS: BAN)
  • SR-33589 (IS)
  • UNII-JQZ1L091Y2 (IS)
  • Dronedarone Hydrochloride (OS: USAN, BANM)
  • SR33598B (IS)
  • UNII-FA36DV299Q (IS)

Brand Names

  • Multaq
    Farmagon, Norway; Sanofi Winthrop, Serbia; Sanofi Winthrop Industrie, Israel; Sanofi-aventis, Greece; Sanofi, United Kingdom; Sanofi, Ireland; Sanofi Aventis, Spain; Sanofi Oy, Finland; Sanofi-Aventis, Austria; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Denmark; Sanofi-Aventis, France; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Iceland; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Netherlands; Sanofi-Aventis, Norway; Sanofi-Aventis, Philippines; Sanofi-Aventis, Poland; Sanofi-Aventis, Portugal; Sanofi-Aventis, Singapore; Sanofi-Aventis, Slovenia
  • MULTAQ
    Sanofi, Sweden; Sanofi-Aventis, Germany; Sanofi-Aventis, Romania
  • Regivas
    Sanofi-Aventis, Mexico

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide